Sor-resistant HCC cells express higher levels of pAkt, m-TOR, pERK, p-STAT3, p-JAK2, but lower levels of SHP-1 and p-SHP-1, indicating that the JAK-STAT pathway participates in the acquired resistance to Sor in HCC. This evidence concerns the gene JAK2 and hepatocellular carcinoma.